U.S. markets closed

Exact Sciences Corporation (EXAS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
118.19+2.32 (+2.00%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close115.87
Open117.32
Bid118.61 x 800
Ask118.15 x 800
Day's Range116.00 - 121.06
52 Week Range35.25 - 141.90
Volume893,609
Avg. Volume2,143,695
Market Cap17.779B
Beta (5Y Monthly)1.89
PE Ratio (TTM)N/A
EPS (TTM)-2.27
Earnings DateFeb 09, 2021 - Feb 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est150.43
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Exact Sciences to participate in December investor conference
    PR Newswire

    Exact Sciences to participate in December investor conference

    Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • Forget Apple! Buy These 2 High-Growth Stocks Instead
    Motley Fool

    Forget Apple! Buy These 2 High-Growth Stocks Instead

    Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.

  • Investor's Business Daily Video

    Exact Sciences Looking Tight

    Exact Sciences look set to have a three-weeks-tight pattern. The company is one of several working on liquid biopsies, with blood tests that can detect multiple cancers. It's the subject of our IBD Cover story this week.